John J. Cadeddu has an estimated net worth of $173 Million. This is based on reported shares across multiple companies, which include Atara Biotherapeutics, Inc., ARMO BioSciences, Inc., MARIN SOFTWARE INC, YuMe Inc, Adamas Pharmaceuticals Inc, WEALTHFRONT CORP, Corner Growth Acquisition Corp., and CORNER GROWTH ACQUISITION CORP. 2.

2013 was John J. Cadeddu's most active year for acquiring shares with 14 total transactions. John J. Cadeddu's most active month to acquire stocks was the month of February. 2013 was John J. Cadeddu's most active year for disposing of shares, totalling 20 transactions. John J. Cadeddu's most active month to dispose stocks was the month of November. 2025 saw John J. Cadeddu paying a total of $0.00 for 13,472,672 shares, this is the most they've acquired in one year. In 2014 John J. Cadeddu cashed out on 2,722,637 shares for a total of $290,228.82, their largest year based on trade value.